Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BRD4 | O60885 | 9/20 | 0.46 |
| ▸ | ATR | Q13535 | 3/20 | 0.41 |
| ▸ | ACACB | O00763 | 1/20 | 0.36 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.34 |
| ▸ | KRAS | P01116 | 1/20 | 0.33 |
| ▸ | RXRA | P19793 | 1/20 | 0.33 |
| ▸ | RXRB | P28702 | 1/20 | 0.33 |
| ▸ | RXRG | P48443 | 1/20 | 0.33 |
| ▸ | DYRK1A | Q13627 | 2/20 | 0.32 |
| ▸ | GSK3B | P49841 | 1/20 | 0.32 |
| ▸ | AAK1 | Q2M2I8 | 1/20 | 0.32 |
| ▸ | FPR3 | P25089 | 1/20 | 0.32 |
| ▸ | FPR2 | P25090 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30797857 | 0.89 | ATR (0.41) | BRD4ATRKRASRXRARXRB | |
| SCHEMBL30797547 | 0.85 | ATR (0.42) | BRD4ATRKRASRXRARXRB | |
| SCHEMBL30797730 | 0.85 | ATR (0.44) | BRD4ATRRXRARXRBRXRG | |
| SCHEMBL30797688 | 0.85 | ATR (0.44) | BRD4ATRKRASRXRARXRB | |
| SCHEMBL30797974 | 0.85 | ATR (0.44) | BRD4ATRKRASRXRARXRB | |
| SCHEMBL30797677 | 0.84 | ATR (0.41) | BRD4ATRRXRARXRBRXRG | |
| SCHEMBL30797714 | 0.84 | ATR (0.41) | BRD4ATRKRASRXRARXRB | |
| SCHEMBL27377168 | 0.84 | ATR (0.41) | BRD4ATRRXRARXRBRXRG | |
| SCHEMBL30797873 | 0.84 | ATR (0.41) | BRD4ATRRXRARXRBRXRG | |
| SCHEMBL27377014 | 0.84 | ATR (0.41) | BRD4ATRRXRARXRBRXRG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4584266-A1 | NOVEL COMPOUNDS, COMPOSITIONS AND THERAPEUTIC USES THEREOF | Cambridge Enterprise Limited (GB) | 2025-07-16 | — | — | EP | disclosed |
| WO-2024052701-A1 | NOVEL COMPOUNDS, COMPOSITIONS AND THERAPEUTIC USES THEREOF | CAMBRIDGE ENTERPRISE LIMITED (GB) | 2024-03-14 | — | — | WO | disclosed |